ArticleInternational immunopharmacology2022

Corrigendum to "A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial" [Int. Immunopharmacol. 96 (2021) 107743].

Alok Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.